Variants in the 3’UTR microRNA binding sites of BCL2L13 have been identified in multiple sclerosis, which may alter BCL2L13 protein expression levels and consequently disrupt key processes such as mitophagy and apoptosis (130). The gene discussed is BCL2L13; the disease is multiple sclerosis.